How to use fluorouracil and imiquimod for non melanoma skin cancer in a general practice setting

Fluorouracil and imiquimod creams are fully subsidised topical treatments, suitable for some patients with non-melanoma skin cancers; Special Authority approval is no longer required for subsidy. Their place in treatment depends on the type, severity and location...

View article

Childhood eczema: improving adherence to treatment basics

Emollients form the basis of treatment for all patients with eczema.

Topical corticosteroids for childhood eczema: clearing up the confusion

Topical corticosteroids are one of the key medicines used in...

Access to HPV vaccine widened

The human papillomavirus virus (HPV) vaccine reduces the incidence of HPV-related...

Oestradiol patches now fully subsidised: what is their place in the treatment of menopausal symptoms?

Transdermal oestradiol patches are now fully subsidised, without the need...

Amiodarone brand-change and a reminder on patient monitoring

Two brands of amiodarone are currently subsidised in New Zealand...

Targeted testing for abdominal aortic aneurysm

A recently published study from the University of Otago provides...

Oxycodone prescribing: New Zealand solutions to a global problem

Inappropriate prescribing of opioids for non-cancer pain is an international problem. In this article...

Treatment of hepatitis C (HCV) has changed

Three new oral medicine regimens for the treatment of hepatitis C, known as directly acting antivirals (DAAs), are fully subsidised...

The COPD prescribing tool

This tool provides pharmacological treatment options for patients with COPD based on their symptom severity.

Made with by the bpacnz team